Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

AR, Chacra; GH, Tan; A, Apanovitch; S, Ravichandran; J, List; R, Chen

doi:10.1111/j.1742-1241.2009.02143.x

Public

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Shared by NobleBlocks on Jul 15, 2009 • 12:00 AM UTC

Authors:

Chacra AR

Tan GH

Apanovitch A

Abstract

<h4>Aims</h4>Assess the efficacy and safety of saxagliptin added to a submaximal sulphonylurea dose vs. uptitration of sulphonylurea monotherapy in patients with type 2 diabetes and inadequate glycaemic control with sulphonylurea monotherapy.<h4>Methods and patients</h4>A total of 768 patients (18-7...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!